Advanced Search

 

Study ID Status Title Patient Level Data
ROTA-Meta-Analysis-201212 Completed Integrated safety summary of GSK Biologicals’ HRV vaccine (Rotarix™)
ROX104805 Completed A 4-Week, Randomized, Double-Blind, Cohort Study to Evaluate the Safety and Tolerability of Converting from Ropinirole Immediate Release (IR) to Ropinirole Extended Release (XR) Formulation in Patients with Restless Legs Syndrome (RLS) Study Listed on ClinicalStudyDataRequest.com
RRL103628 Completed An Open-Label, Parallel-Group, Repeat-Dose Study to Investigate the Effects of End Stage Renal Disease and Haemodialysis on the Pharmacokinetics of Ropinirole (Study RRL103628) Study Listed on ClinicalStudyDataRequest.com
RRL103660 Completed A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients with Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep Study Listed on ClinicalStudyDataRequest.com
RRL106721 Completed A multicenter 3:1-randomized placebo-controlled double-blind Phase IIIb study on the effects of Ropinirole on mood/(subclinical) depression in the therapy of patients with moderate to severe idiopathic RLS in Germany
RXP110908 Completed Study RXP110908, a polysomnography study of GSK1838262 (XP13512) extended release tablets versus placebo in the treatment of Restless Legs Syndrome (RLS) and associated sleep disturbance
S2110367 Completed A Randomized, Open Label Study to Evaluate the Oral Tolerability of a Nicotine Prototype
S2111378 Completed A Pilot Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Strip, Nicorette ® Nicotine Lozenge and Gum
S2W106188 Completed A multicenter study to determine the clinical characteristics of the temporal aspects of migraine in a Canadian population: Clinical Study Of Migraine Evolution (C-SOME)
S3010567 Completed A Single Dose Bioequivalence Study of 2mg and 4mg Nicotine Lozenges
S3250493 Completed Simultaneous fMRI/EEG of the 4 mg Nicotine Lozenge in Relief of Cognitive Impairment Associated with Nicotine Withdrawal
S3820642 Completed A Pharmacokinetic Evaluation of Nicotine Patches in Smokers
S3B20032 Completed A four-week, open, multicenter study to assess the safety and efficacy of 1 mg once daily (QD) of GR68755 in female subjects with severe diarrhea-predominant irritable bowel syndrome (IBS) who have frequent bowel urgency
S3B30040 Completed A Twelve-Week, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 0.5 mg QD, 1 mg QD and 1 mg BID of Alosetron in Female Subjects with Severe Diarrhea-predominant IBS Who Have Failed Conventional Therapy
S3B30048 Completed A 12-Week, Randomized, Double-Blind, Placebo- Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects with Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy
S3B40042 Completed A randomize, placebo-controlled, crossover study to measure the effect of alosetron on mucosal blood flow in female healthy volunteers and diarrhea-predominant IBS subjects
S6491365 Completed A Single Dose Bioequivalence Study of 2 different doses of Mini Cherry Nicotine Lozenges
S7120994 Completed Evaluation of the nicotine lozenge in relief of provoked acute craving
S7121359 Completed Evaluation of the Nicotine Mini Lozenge in Relief of Provoked Acute Craving
SAM 106538 Completed Asthma control assessment via ACT and DRC in Asthmatics treated with Seretide (50/250) over 12 weeks
SAM101667 Completed A multicentre, randomised, double-blind, parallel group study to compare the efficacy and safety of Salmeterol/Fluticasone propionate combination product (Seretide®) 50/100 mcg with Fluticasone propionate (Flixotide® ) 200 mcg, both delivered twice daily via the DISKUS inhaler, in the treatment of children aged 6-12 years with symptomatic asthma
SAM103848 Completed Randomised, double-blind, double-dummy, parallel-group, comparative study of salmeterol/FP 50/100mcg bd inhalation powder via Diskus with oral Montelukast (5mg QD) chewable tablets in Children 6-14 years
SAM103976 Completed SERETIDE vs FLIXOTIDE in mild persistent asthma (GINAII)
SAM104926 Completed A multicentre, randomised, double-blind, double dummy, parallel group study to compare the salmeterol/fluticasone propionate combination (SeretideTM) at a dose of 50/100µg twice daily and fluticasone propionate (FlixotideTM) at a dose of 200µg twice daily, both delivered via a dry powder inhaler (DiskusTM) for 12 weeks in asthma in children aged 4-11 years not controlled by inhaled corticosteroids alone at medium dose
SAM108037 Terminated Seretide 100 DK vs Flixotide 100 DK in IMT in moderate asthma in adults on static lung volumes (mechanistic study)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.